melanoma and non-melanoma


Skin cancer is one of the most common cancers in the world. Non-melanoma skin cancer (NMSC) refers to a group of cancers that slowly develop in the upper layers of the skin. The term non-melanoma distinguishes these more common types of skin cancer from the less common skin cancer known as melanoma (MSC), which can be more serious.

Melanoma is a type of skin cancer that develops when melanocytes (the cells that give the skin its tan or brown color) start to grow out of control. Melanoma is much less common than some other types of skin cancers. But melanoma is more dangerous because it is much more likely to spread to other parts of the body if not caught and treated early.

Early-stage melanomas can often be treated with surgery alone, but more advanced cancers often require other treatments. Sometimes more than one type of treatment is used. Promising results based on systemic radionuclide therapy represent a novel approach for the therapy of malignant melanoma and are of considerable potential. Intralesional Targeted Alpha Therapies (TAT) for melanoma clinical trials was found to be efficacious and a promising therapy for the control of inoperable secondary melanoma or primary ocular melanoma.

Sources:, SNM Journals,, NHS UK


166Ho-Chitosan (Brachytherapy – melanoma)

188Rhenium Skin Cancer Therapy (Brachytherapy – Non-Melanoma skin cancer)





Understanding Melanoma – American cancer Society

Melanoma Treatment – National Cancer Institute NIH


Compassionate Use Program (CUP)

CUP enables patients with life-threatening diseases, such as advanced cancer, to resort to experimental treatments when standard anti-cancer solutions and access to clinical trials are not an option. Access to CUP programs depends on local regulations and can vary from one treatment to another.

Ask your referring physicians for more information regarding CUP.